Target intelligence / Profile preview

Chemokine (C-C motif) ligand 3 (CCL3)

Target
CCL3
Molecular classification
Cytokine, Chemokine, Immune signaling molecule
01

Overview

Chemokine (C-C motif) ligand 3 (CCL3) is a small **cytokine** of the **CC chemokine family** that plays a key role in mediating and regulating acute inflammatory responses by attracting and activating leukocytes such as macrophages, monocytes, and neutrophils[2][4][6]. CCL3 exerts its effects via several chemokine receptors, primarily **CCR1, CCR4, and CCR5**, making it a pivotal regulator of immune cell migration and effector functions, especially during infection and inflammation[2][4][6]. It is implicated in disease states related to immune hyperactivity (autoimmunity, neuroinflammation) as well as in tumor immune surveillance[4][5][6]. CCL3 is also known as macrophage inflammatory protein 1-alpha (MIP-1-alpha), and its gene is located on human chromosome 17[2].

Other names
Macrophage inflammatory protein 1-alpha (MIP-1-alpha)MIP1ALD78alpha
02

Mechanism of action

Inhibits leukocyte migration by blocking its receptors (CCR1, CCR4, CCR5); drugs target downstream effects such as HIV entry inhibition (e.g., CCR5 antagonists)

03

Biological functions

Immune responseChemotaxisLeukocyte activationInflammation
04

Disease associations

InflammationInfectionNeuroinflammatory diseaseCancer
05

Safety considerations

Potential immune suppression if antagonizedrisk of infectionmodulation may alter CD8+ T cell function and cytolytic activity
06

Interacting drugs

Maraviroc (blocks CCR5, a receptor for CCL3)

1 more in the full profile.

07

Biomarkers

Circulating CCL3 levels as an inflammation biomarkermay be elevated in infection or inflammatory disease

Beyond the preview

Go deeper on Chemokine (C-C motif) ligand 3 (CCL3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chemokine (C-C motif) ligand 3 (CCL3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call